Does the media favor COIN or SI?

In the previous week, Coinbase Global had 65 more articles in the media than Shoulder Innovations. MarketBeat recorded 69 mentions for Coinbase Global and 4 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.58 beat Shoulder Innovations' score of -0.53 indicating that Coinbase Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coinbase Global 32 Very Positive mention(s) 15 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 5 Very Negative mention(s) Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media refer more to EYE or SI?

In the previous week, Shoulder Innovations had 3 more articles in the media than National Vision. MarketBeat recorded 4 mentions for Shoulder Innovations and 1 mentions for National Vision. National Vision's average media sentiment score of 1.52 beat Shoulder Innovations' score of -0.53 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media favor BLFS or SI?

In the previous week, Shoulder Innovations had 3 more articles in the media than BioLife Solutions. MarketBeat recorded 4 mentions for Shoulder Innovations and 1 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 0.84 beat Shoulder Innovations' score of -0.53 indicating that BioLife Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media prefer ENOV or SI?

In the previous week, Enovis had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 5 mentions for Enovis and 4 mentions for Shoulder Innovations. Enovis' average media sentiment score of 1.04 beat Shoulder Innovations' score of -0.53 indicating that Enovis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media favor SI or PRCT?

In the previous week, Shoulder Innovations had 3 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 4 mentions for Shoulder Innovations and 1 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.62 beat Shoulder Innovations' score of -0.53 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative PROCEPT BioRobotics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Shoulder Innovations (SI) Competitors

$18.67 +0.90 (+5.06%)

As of 01:15 PM Eastern

Compare

SI vs. COIN, EYE, BLFS, ENOV, and PRCT

Should you buy Shoulder Innovations stock or one of its competitors? MarketBeat compares Shoulder Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shoulder Innovations include Coinbase Global (COIN), National Vision (EYE), BioLife Solutions (BLFS), Enovis (ENOV), and PROCEPT BioRobotics (PRCT).

How does Shoulder Innovations compare to Coinbase Global?

Coinbase Global (NASDAQ:COIN) and Shoulder Innovations (NYSE:SI) are related companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

68.8% of Coinbase Global shares are owned by institutional investors. 16.7% of Coinbase Global shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Coinbase Global has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Coinbase Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coinbase Global	$7.18B	5.82	$1.26B	$2.66	59.62
Shoulder Innovations	$53.89M	7.18	-$40.36M	-$166.96	N/A

Coinbase Global currently has a consensus target price of $250.65, suggesting a potential upside of 58.04%. Shoulder Innovations has a consensus target price of $21.00, suggesting a potential upside of 12.48%. Given Coinbase Global's higher probable upside, equities research analysts clearly believe Coinbase Global is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coinbase Global	3 Sell rating(s)	12 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.45
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Coinbase Global has a net margin of 12.20% compared to Shoulder Innovations' net margin of -81.78%. Coinbase Global's return on equity of 4.16% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Coinbase Global	12.20%	4.16%	2.07%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

In the previous week, Coinbase Global had 65 more articles in the media than Shoulder Innovations. MarketBeat recorded 69 mentions for Coinbase Global and 4 mentions for Shoulder Innovations. Coinbase Global's average media sentiment score of 0.58 beat Shoulder Innovations' score of -0.53 indicating that Coinbase Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Coinbase Global	32 Very Positive mention(s)	15 Positive mention(s)	12 Neutral mention(s)	1 Negative mention(s)	5 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

Coinbase Global beats Shoulder Innovations on 12 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to National Vision?

National Vision (NASDAQ:EYE) and Shoulder Innovations (NYSE:SI) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

National Vision has a net margin of 2.31% compared to Shoulder Innovations' net margin of -81.78%. National Vision's return on equity of 6.41% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

National Vision currently has a consensus target price of $30.08, suggesting a potential upside of 75.36%. Shoulder Innovations has a consensus target price of $21.00, suggesting a potential upside of 12.48%. Given National Vision's stronger consensus rating and higher possible upside, research analysts clearly believe National Vision is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

National Vision has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$2.02B	0.68	$29.60M	$0.57	30.10
Shoulder Innovations	$53.89M	7.18	-$40.36M	-$166.96	N/A

In the previous week, Shoulder Innovations had 3 more articles in the media than National Vision. MarketBeat recorded 4 mentions for Shoulder Innovations and 1 mentions for National Vision. National Vision's average media sentiment score of 1.52 beat Shoulder Innovations' score of -0.53 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

National Vision beats Shoulder Innovations on 11 of the 13 factors compared between the two stocks.

How does Shoulder Innovations compare to BioLife Solutions?

BioLife Solutions (NASDAQ:BLFS) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

BioLife Solutions has higher revenue and earnings than Shoulder Innovations. BioLife Solutions is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$96.21M	12.77	-$4.59M	-$0.08	N/A
Shoulder Innovations	$53.89M	7.18	-$40.36M	-$166.96	N/A

In the previous week, Shoulder Innovations had 3 more articles in the media than BioLife Solutions. MarketBeat recorded 4 mentions for Shoulder Innovations and 1 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 0.84 beat Shoulder Innovations' score of -0.53 indicating that BioLife Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioLife Solutions	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

BioLife Solutions currently has a consensus target price of $32.00, indicating a potential upside of 27.26%. Shoulder Innovations has a consensus target price of $21.00, indicating a potential upside of 12.48%. Given BioLife Solutions' higher probable upside, equities research analysts plainly believe BioLife Solutions is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

93.2% of BioLife Solutions shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

BioLife Solutions has a net margin of -2.80% compared to Shoulder Innovations' net margin of -81.78%. BioLife Solutions' return on equity of 1.81% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-2.80%	1.81%	1.65%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

Summary

BioLife Solutions beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to Enovis?

Enovis (NYSE:ENOV) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Enovis presently has a consensus target price of $44.50, indicating a potential upside of 108.24%. Shoulder Innovations has a consensus target price of $21.00, indicating a potential upside of 12.48%. Given Enovis' stronger consensus rating and higher possible upside, analysts plainly believe Enovis is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Shoulder Innovations has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25B	0.55	-$1.18B	-$19.88	N/A
Shoulder Innovations	$53.89M	7.18	-$40.36M	-$166.96	N/A

98.5% of Enovis shares are held by institutional investors. 2.9% of Enovis shares are held by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Enovis has a net margin of -49.92% compared to Shoulder Innovations' net margin of -81.78%. Enovis' return on equity of 10.32% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-49.92%	10.32%	4.57%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

In the previous week, Enovis had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 5 mentions for Enovis and 4 mentions for Shoulder Innovations. Enovis' average media sentiment score of 1.04 beat Shoulder Innovations' score of -0.53 indicating that Enovis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

Enovis beats Shoulder Innovations on 11 of the 15 factors compared between the two stocks.

How does Shoulder Innovations compare to PROCEPT BioRobotics?

Shoulder Innovations (NYSE:SI) and PROCEPT BioRobotics (NASDAQ:PRCT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Shoulder Innovations currently has a consensus price target of $21.00, suggesting a potential upside of 12.48%. PROCEPT BioRobotics has a consensus price target of $41.36, suggesting a potential upside of 104.29%. Given PROCEPT BioRobotics' higher possible upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
PROCEPT BioRobotics	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.36

Shoulder Innovations has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$53.89M	7.18	-$40.36M	-$166.96	N/A
PROCEPT BioRobotics	$308.05M	3.74	-$95.57M	-$1.82	N/A

In the previous week, Shoulder Innovations had 3 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 4 mentions for Shoulder Innovations and 1 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.62 beat Shoulder Innovations' score of -0.53 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
PROCEPT BioRobotics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

PROCEPT BioRobotics has a net margin of -31.82% compared to Shoulder Innovations' net margin of -81.78%. PROCEPT BioRobotics' return on equity of -27.70% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
PROCEPT BioRobotics	-31.82%	-27.70%	-20.29%

Summary

PROCEPT BioRobotics beats Shoulder Innovations on 9 of the 15 factors compared between the two stocks.

Get Shoulder Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SI vs. The Competition

Export

Metric	Shoulder Innovations	Surgical, Medical, And Dental Instruments And Supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$387.08M	$2.68B	$6.50B	$23.20B
Dividend Yield	N/A	N/A	2.68%	4.06%
P/E Ratio	-0.11	13.27	24.67	31.21
Price / Sales	7.18	364.18	532.48	21.09
Price / Cash	N/A	7.99	27.92	18.65
Price / Book	2.73	6.01	10.89	4.68
Net Income	-$40.36M	$7.39M	$3.56B	$1.08B
7 Day Performance	-0.57%	-3.74%	2.19%	-0.85%
1 Month Performance	27.25%	-7.78%	0.94%	0.38%
1 Year Performance	N/A	11.11%	33.91%	24.76%

Shoulder Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SI Shoulder Innovations	2.5411 of 5 stars	$18.67 +5.1%	$21.00 +12.5%	N/A	$387.08M	$53.89M	N/A	61	News Coverage
COIN Coinbase Global	4.3856 of 5 stars	$163.26 flat	$250.65 +53.5%	-46.5%	$43.01B	$7.18B	61.38	4,951	Gap Down
EYE National Vision	4.0022 of 5 stars	$16.78 flat	$30.08 +79.3%	-25.9%	$1.34B	$2.02B	29.44	13,138	Positive News High Trading Volume
BLFS BioLife Solutions	3.3877 of 5 stars	$26.04 flat	$32.00 +22.9%	+17.3%	$1.27B	$96.21M	N/A	440
ENOV Enovis	4.3089 of 5 stars	$21.95 -0.1%	$44.50 +102.7%	-29.2%	$1.26B	$2.25B	N/A	7,802	Positive News Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SI) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shoulder Innovations (SI) Competitors

SI vs. COIN, EYE, BLFS, ENOV, and PRCT

How does Shoulder Innovations compare to Coinbase Global?

Summary

How does Shoulder Innovations compare to National Vision?

Summary

How does Shoulder Innovations compare to BioLife Solutions?

Summary

How does Shoulder Innovations compare to Enovis?

Summary

How does Shoulder Innovations compare to PROCEPT BioRobotics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shoulder Innovations (SI) Competitors

SI vs. COIN, EYE, BLFS, ENOV, and PRCT

How does Shoulder Innovations compare to Coinbase Global?

Do insiders & institutionals hold more shares of COIN or SI?

Which has better valuation and earnings, COIN or SI?

Do analysts prefer COIN or SI?

Is COIN or SI more profitable?

Does the media favor COIN or SI?

Summary

How does Shoulder Innovations compare to National Vision?

Is EYE or SI more profitable?

Do analysts recommend EYE or SI?

Which has higher valuation and earnings, EYE or SI?

Does the media refer more to EYE or SI?

Summary

How does Shoulder Innovations compare to BioLife Solutions?

Which has higher earnings and valuation, BLFS or SI?

Does the media favor BLFS or SI?

Do analysts prefer BLFS or SI?

Do insiders & institutionals believe in BLFS or SI?

Is BLFS or SI more profitable?

Summary

How does Shoulder Innovations compare to Enovis?

Do analysts recommend ENOV or SI?

Which has higher valuation and earnings, ENOV or SI?

Do institutionals & insiders have more ownership in ENOV or SI?

Is ENOV or SI more profitable?

Does the media prefer ENOV or SI?

Summary

How does Shoulder Innovations compare to PROCEPT BioRobotics?

Do institutionals and insiders hold more shares of SI or PRCT?

Do analysts recommend SI or PRCT?

Which has stronger valuation and earnings, SI or PRCT?

Does the media favor SI or PRCT?

Is SI or PRCT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools